Story excerpt provided by Columbus Business First.
Written by Carrie Ghose.
Milo Biotechnology LLC, a Nationwide Children’s Hospital spinoff that has raised $400,000, is progressing “crazy fast” toward applying for regulatory approval for a gene therapy for muscular dystrophy and other muscle-wasting disorders, its CEO said.
Click here to read the complete article.
Originally published June 15, 2016.